Cargando…

LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary

Parkinson's disease is the most common neurodegenerative movement disorder and affects about 2% of the population over the age of 60 years. In 2004, mutations in the LRRK2 gene were first described and turned out to be the most frequent genetic cause of familial and sporadic Parkinson's di...

Descripción completa

Detalles Bibliográficos
Autor principal: Krüger, Rejko
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607298/
https://www.ncbi.nlm.nih.gov/pubmed/18986509
http://dx.doi.org/10.1186/1741-7015-6-33
_version_ 1782163047094157312
author Krüger, Rejko
author_facet Krüger, Rejko
author_sort Krüger, Rejko
collection PubMed
description Parkinson's disease is the most common neurodegenerative movement disorder and affects about 2% of the population over the age of 60 years. In 2004, mutations in the LRRK2 gene were first described and turned out to be the most frequent genetic cause of familial and sporadic Parkinson's disease and may account for up to 40% of patients in distinct populations. Based on these findings, Latourelle and colleagues show that the penetrance of the most common LRRK2 mutation is higher in patients with familial compared with sporadic Parkinson's disease and identified a substantial number of affected relatives of mutation carriers not presenting with a LRRK2 mutation themselves. This commentary discusses the role of genetic and/or environmental susceptibility factors modulating the expressivity of the disease trait, how these factors may contribute to the phenomenon of phenocopies in genetically defined Parkinson's disease pedigrees, and how the findings of Latourelle and colleagues, published this month in BMC Medicine, relate to current concepts of genetic counselling.
format Text
id pubmed-2607298
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26072982008-12-24 LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary Krüger, Rejko BMC Med Commentary Parkinson's disease is the most common neurodegenerative movement disorder and affects about 2% of the population over the age of 60 years. In 2004, mutations in the LRRK2 gene were first described and turned out to be the most frequent genetic cause of familial and sporadic Parkinson's disease and may account for up to 40% of patients in distinct populations. Based on these findings, Latourelle and colleagues show that the penetrance of the most common LRRK2 mutation is higher in patients with familial compared with sporadic Parkinson's disease and identified a substantial number of affected relatives of mutation carriers not presenting with a LRRK2 mutation themselves. This commentary discusses the role of genetic and/or environmental susceptibility factors modulating the expressivity of the disease trait, how these factors may contribute to the phenomenon of phenocopies in genetically defined Parkinson's disease pedigrees, and how the findings of Latourelle and colleagues, published this month in BMC Medicine, relate to current concepts of genetic counselling. BioMed Central 2008-11-05 /pmc/articles/PMC2607298/ /pubmed/18986509 http://dx.doi.org/10.1186/1741-7015-6-33 Text en Copyright © 2008 Krüger; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Krüger, Rejko
LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary
title LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary
title_full LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary
title_fullStr LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary
title_full_unstemmed LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary
title_short LRRK2 in Parkinson's disease – drawing the curtain of penetrance: a commentary
title_sort lrrk2 in parkinson's disease – drawing the curtain of penetrance: a commentary
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2607298/
https://www.ncbi.nlm.nih.gov/pubmed/18986509
http://dx.doi.org/10.1186/1741-7015-6-33
work_keys_str_mv AT krugerrejko lrrk2inparkinsonsdiseasedrawingthecurtainofpenetranceacommentary